USA Today Exposes Insufficient Efforts to Stop the Deadly Bacteria Known as C. diff

This month, USA Today ran a major article entitled, “Far more could be done to stop the deadly bacteria C. diff”.  The publication’s investigation into this pathogenic bacterium, officially known as Clostridium difficile, found that it is linked to more than 30,000 deaths each year in the United States.  These figures are approximately double those of federal estimates.
 
The article reveals that there is much more that can be done to prevent these deaths and the 500,000 infections contracted each year.  It states, “… despite a decade of rising C. diff rates, health care providers and the government agencies that oversee them have been slow to adopt proven strategies to reduce the infections, resulting in tens of thousands of deaths and illnesses that could have been prevented, the investigation shows.”
 
C. diff is a bacterium that may develop into infections under prolonged use of antibiotics during healthcare treatment.  C. diff infections cause diarrhea and more serious intestinal conditions such as colitis.  It is a major culprit in healthcare-associated infections (HAIs) and has also been increasingly identified as a community-acquired infection.
 
According to the U.S. Centers for Disease Control and Prevention (CDC), “Clostridium difficile is shed in feces. Any surface, device, or material that becomes contaminated with feces may serve as a reservoir for the Clostridium difficile spores. Clostridium difficile spores are transferred to patients mainly via the hands of healthcare personnel who have touched a contaminated surface or item. Clostridium difficile can live for long periods on surfaces.”
 
One company that has developed new technologies for superior surface disinfection for battling C. diff and other microbial pathogens in the healthcare sector is UltraViolet Devices, Inc. (UVDI).  “UVDI’s V-360° Room Sanitizer is a portable device that provides an effective, non-contact solution that utilizes ultraviolet energy to quickly provide decontamination of microbial pathogens in healthcare environments,” reported Richard Hayes, President of UVDI.  “Third party testing has proven a 99.9% reduction of C. diff spores with 10 minutes of exposure to the V-360° Room Sanitizer at a distance of 8 feet.  When properly applied, this technology achieves much higher levels of surface disinfection than is typical with current use of chemical disinfectants.”
 
An informational video about the V-360° Room Sanitizer may be viewed at:  https://vimeo.com/43824277
 
 
To learn more about UVDI or how ultraviolet energy can be utilized to deactivate microbial pathogens, please visit http://www.uvdi.com, email info@UVDI.com or call (877) 787-3882.
 
About UltraViolet Devices, Inc.
UVDI is a leading manufacturer and supplier of UV products for air, surface and water disinfection. Under the ALTRU-V® brand, UVDI markets a full line of products for the HVACR market designed to reduce energy consumption and lower maintenance costs while delivering cleaner, healthier air.  Under UVDI’s Sparks Technology™ brand, the company markets gas phase filtration products for use in commercial and industrial applications worldwide. UVDI MED provides hospital grade UV disinfection technologies engineered for the healthcare industry.

Contact Information

Paul Cochrane

President

Cochrane & Associates, LLC

Contact via E-mail